Table 1.
Demographic characteristics of the study cohort at baseline
| Number of patients | 264 |
|---|---|
| Men/female, n | 171:93 |
| Age, years ± SD | 73.4 ± 8.8 |
| Diabetes duration, years ± SD | 16.2 ± 13.7 |
| BMI, Kg/m2 ± SD | 26.4 ± 5.0 |
| Smoking (current), n (%) | 63 (23.8) |
| Smoking (former), n (%) | 120 (45.5) |
| Hypertension, n (%) | 204 (77.3) |
| Hypercholesterolemia, n (%) | 243 (92.0) |
| CAD, n (%) | 117 (44.3) |
| CVD, n (%) | 99 (37.5) |
| Rutherford II-4, n (%) | 54 (20.4) |
| Rutherford III-5, n (%) | 108 (40.9) |
| Rutherford III-6, n (%) | 42 (15.9) |
| HbA1c, % ± SD | 7.1 ± 1.2 |
| FBG, mg/dL ± SD | 132.8 ± 54.5 |
| Total cholesterol, mg/dL ± SD | 134.5 ± 34.8 |
| LDL cholesterol, mg/dL ± SD | 71.4 ± 28.5 |
| HDL cholesterol, mg/dL ± SD | 38.3 ± 11.9 |
| Triglycerides, mg/dL ± SD | 119.3 ± 63.5 |
| Creatinine, mg/dL ± SD | 1.8 ± 1.8 |
| IL1, pg/mL ± SD | 77.4 ± 18.8 |
| IL6, pg/mL ± SD | 56.3 ± 25.7 |
| CRP, mg/L ± SD | 21.3 ± 18.0 |
| TNFα, pg/mL ± SD | 45.3 ± 20.8 |
| OPG pg/mL ± SD | 509.9 ± 182.1 |
| HMGB1, pg/mL ± SD | 591.2 ± 197.4 |
| Omentin1, ng/mL ± SD | 28.0 ± 11.3 |
| Sortilin, ng/mL ± SD | 1.6 ± 0.5 |
Data are reported as means (standard deviation) for continuous variables and numbers (percentages) for categorical variables. BMI, body mass index; CAD, coronary artery disease; CVD, cerebrovascular disease; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate